Literature DB >> 20173390

T cells as sources and targets of TNF: implications for immunity and autoimmunity.

Ioannis Chatzidakis1, Clio Mamalaki.   

Abstract

TNF is a pleiotropic cytokine produced by many cell types upon different stimuli and in various physiological and pathological conditions. In this review, we focus on the role of TNF in T cell responses as demonstrated by in vitro and in vivo observations in mice and humans. TNF has an impact on all aspects of T cell biology such as development in the thymus, peripheral homeostasis, primary antigenic responses, apoptosis, effector functions, memory cell formation and tolerance induction and maintenance. In most cases, TNF has an immunostimulatory role in T cell responses; however, under certain conditions, TNF can exert immunomodulatory effects on T cells. We also review how T cell-derived TNF is an important component of T cell immunity as exemplified by many studies involving intracellular pathogens and tumors. Finally, we summarize how TNF T cells interplay contributes to pathology in autoimmune disorders and what is known about the effect of widely used TNF blockers on T cell differentiation/function. Copyright (c) 2010 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20173390     DOI: 10.1159/000289200

Source DB:  PubMed          Journal:  Curr Dir Autoimmun        ISSN: 1422-2132


  18 in total

Review 1.  Contrasting effects of TNF and anti-TNF on the activation of effector T cells and regulatory T cells in autoimmunity.

Authors:  Xin Chen; Joost J Oppenheim
Journal:  FEBS Lett       Date:  2011-04-15       Impact factor: 4.124

Review 2.  Concordance of preclinical and clinical pharmacology and toxicology of monoclonal antibodies and fusion proteins: soluble targets.

Authors:  Pauline L Martin; Peter J Bugelski
Journal:  Br J Pharmacol       Date:  2012-06       Impact factor: 8.739

3.  TNFR2 is critical for the stabilization of the CD4+Foxp3+ regulatory T. cell phenotype in the inflammatory environment.

Authors:  Xin Chen; Xueqiang Wu; Qiong Zhou; O M Zack Howard; Mihai G Netea; Joost J Oppenheim
Journal:  J Immunol       Date:  2012-12-31       Impact factor: 5.422

4.  Tumor necrosis factor alpha production from CD8+ T cells mediates oviduct pathological sequelae following primary genital Chlamydia muridarum infection.

Authors:  Ashlesh K Murthy; Weidang Li; Bharat K R Chaganty; Sangamithra Kamalakaran; M Neal Guentzel; J Seshu; Thomas G Forsthuber; Guangming Zhong; Bernard P Arulanandam
Journal:  Infect Immun       Date:  2011-05-02       Impact factor: 3.441

Review 5.  Gene therapy for brain tumors: basic developments and clinical implementation.

Authors:  Hikmat Assi; Marianela Candolfi; Gregory Baker; Yohei Mineharu; Pedro R Lowenstein; Maria G Castro
Journal:  Neurosci Lett       Date:  2012-08-10       Impact factor: 3.046

Review 6.  The effect of targeted rheumatoid arthritis therapies on anti-citrullinated protein autoantibody levels and B cell responses.

Authors:  S Modi; M Soejima; M C Levesque
Journal:  Clin Exp Immunol       Date:  2013-07       Impact factor: 4.330

7.  Small molecule inhibition of 6-phosphofructo-2-kinase suppresses t cell activation.

Authors:  Sucheta Telang; Brian F Clem; Alden C Klarer; Amy L Clem; John O Trent; Richard Bucala; Jason Chesney
Journal:  J Transl Med       Date:  2012-05-16       Impact factor: 5.531

8.  A model for cancer-suppressive inflammation.

Authors:  Ole Audun Werner Haabeth; Bjarne Bogen; Alexandre Corthay
Journal:  Oncoimmunology       Date:  2012-10-01       Impact factor: 8.110

9.  Dynamics of a cytokine storm.

Authors:  Hao Hong Yiu; Andrea L Graham; Robert F Stengel
Journal:  PLoS One       Date:  2012-10-01       Impact factor: 3.240

10.  Tumor necrosis factor alpha secreted from oral squamous cell carcinoma contributes to cancer pain and associated inflammation.

Authors:  Nicole N Scheff; Yi Ye; Aditi Bhattacharya; Justin MacRae; Dustin N Hickman; Atul K Sharma; John C Dolan; Brian L Schmidt
Journal:  Pain       Date:  2017-12       Impact factor: 7.926

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.